LiVDerm Deep Dive: Dermatology on the Frontlines: A Clinical Update for Primary Care Physicians

Live Webinar
April 24, 2021

Activity Overview

Medical training for primary care professionals and frontline practitioners typically does not cover the myriad of dermatologic conditions that will be seen in practice. Due to certain patients’ lack of access to a dermatologist or lack of awareness of their dermatologic condition, a primary care practitioner, family medicine or internal medicine physician is commonly faced with the expectation of the diagnoses and treatment of several of these skin conditions.

Join us for a program which will cover the most relevant dermatology topics for frontline practitioners, how to manage these different conditions that present themselves regularly and prepare you for diagnosing infrequent conditions and when to refer those out to a specialist.

Dermatology on the Frontlines is a 7-hour bootcamp designed to educate primary care physicians on how to recognize symptoms, and then either treat or refer patients with skin disorders. This program will cover the most relevant topics for PCPs including common skin conditions such as atopic dermatitis, psoriasis, acne, viral and fungal infections, cutaneous oncology, and common hair and nail conditions. With a panel of experts, multiple patient cases, and interactive questions to test your knowledge, participants can gain the skills and confidence to better care for patients with skin conditions, whether they pursue treatment or referral to a specialist.

Target Audience

This activity is designed to meet the needs physicians, nurses and professional staff members of medical practices.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Recognize the role of PCPs in evaluating patients with dermatologic conditions who face barriers to care
  • Review current and emerging treatment options for acne vulgaris and acne rosacea.
  • Recall current and emerging treatment options for psoriasis
  • Summarize current and emerging treatment options for AD
  • Discuss the potential of emerging non-invasive approaches for early detection of skin cancers
  • Articulate the clinical features of fungal and viral skin infections for accurate and early diagnosis
  • Interpret the various underlying etiologies for forms of hair loss often encountered by PCPs

Criteria for Success

Certificates of completion will be awarded based on the participant’s attendance and submission of the activity evaluation/claim credit form at
You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at


Credit provided by AKH Inc., Advancing Knowledge in Healthcare

Jointly Accredited Provider

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


5.5 ANCC contact hours

Commercial Support

This activity is supported by educational grants from Abbvie and Incyte Corporation.


It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.





April Armstrong, MD


Nothing to disclose

David Goldberg, MD, JD


Nothing to disclose

Amy McMichael, MD


Allergan, Almirall, Bioniz, Cassiopea, Covance, eResearch Technology, Inc., Galderma, Incyte, Johnson & Johnson, Keranetics, Lilly, Merck & Co., Inc., Pfizer Proctor & Gamble, Revian, Samumed

Contracted Research

Allergan, Cassiopea, Concert Pharmaceuticals, Incyte, Pfizer Proctor & Gamble, Samumed


Informa Healthcare, UpToDate

Linda Stein Gold, MD


Galderma, Sun, Pfizer, Amgen, Sanofi, Regeneron, Vyne Therapeutics Inc, Almirall, BMS, UCB, Sol Gel, Ortho Derm

Contracted Research

Galderma, Sun, Pfizer, Amgen, Sanofi, Regeneron, Vyne Therapeutics Inc, Almirall, UCB, Sol Gel, Ortho Derm, Novartis, AbbVie

Speakers Bureau

Galderma, Sun, Pfizer, Amgen, Sanofi, Regeneron, Vyne Therapeutics Inc, Ortho Derm

Dorothy Caputo, MA, BSN, RN - CE Director of Accreditations


Nothing to disclose

LiVDerm Planners and Reviewers


Nothing to disclose

AKH Planners and Reviewers


Nothing to disclose

All of the relevant financial relationships listed for these individuals have been mitigated.


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Call us to discuss which services would best fit your needs